- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Venture Capital
SCHREIBER: Innovation will drive health care industry
May 12, 2012
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
MoreIndiana life sciences leaders look toward the future
July 30, 2011
Chris O'MalleyFormer Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez
and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry
in Indiana to venture capital and Purdue's Discovery Park.
MoreIndianapolis tech experts talk about the local industry
April 9, 2011
In a question-and-answer forum, leaders weigh in on topics ranging from tech transfer to the future of Aprimo.
MoreLife sciences deals pick up momentum
July 28, 2010
J.K. WallVenture dollars for Indiana life sciences companies are still few, but the flow of deals is picking up. Nine Hoosier companies
scored investments totaling $10.4 million during the first six months of the year.
MoreLilly launching new venture capital fund
December 10, 2009
J.K. WallThe fund would acquire experimental drugs and use Lilly R&D staff to try to prove their effectiveness, perhaps boosting Lilly's
drug pipeline.
MoreIndianapolis-based FAST Diagnostics gets funding from BioCrossroads' seed fund
October 24, 2009
IBJ StaffMoney will help the company refine its tool to treat acute kidney injury.
MoreEmerging life sciences companies grabbing more in government grants
August 10, 2009
Chris O'MalleyMore emerging life science companies have found life in the form of federal
Small Business Innovation Research grants.
MoreLilly reorganizes venture capital unit
August 10, 2009
Peter SchnitzlerEli Lilly and Co. has reorganized its venture capital division and simultaneously poured in an additional $25 million.More
Lilly software spinoff Maaguzi sells for $11 million
August 3, 2009
Chris O'MalleyInvestors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though
it’s far from the lucrative payoff they’d once imagined.
MoreIs Indiana coming out of venture capital swoon?
August 3, 2009
IBJ StaffCarmel-based Dormir LLC’s announcement July 29 of $12 million in venture financing was the second local life sciences
deal announced in July. It could suggest a turnaround from a woeful second-quarter performance, when Indiana life
sciences firms announced zero venture capital deals.
MorePurdue student venture fund invests in Kylin Therapeutics
March 16, 2009
Purdue University's Student-Managed Venture Fund is betting its bank on West Lafayette-based biotech startup Kylin Therapeutics
Inc.
MoreProprietary developments withering from recession
March 16, 2009
Scott OlsonFinancing is the lifeblood of companies turning intellectual property into a product or service, but turbulent economic conditions
have made it increasingly difficult to raise cash from investors who are content to wait
out the storm by concentrating on their existing portfolios.
MoreVenture capital fund launched by up-and-comers buys into Vontoo, Compendium Blogware
March 9, 2009
Peter SchnitzlerSeveral venture capitalists — a generation younger than most in the profession — are establishing themselves in
Indianapolis.
MoreNote to Hoosier entrepreneurs: Fight on!
December 22, 2008
Jon FordGreat leaders are not born out of good times â?? they are born out of severe challenge.
MoreEli Lilly investing $100M in China, hoping to attract research partners
December 1, 2008
Brian SpegeleHoping to increase sales in China's rapidly growing pharmaceutical market, Eli Lilly and Co. is charging ahead
with
plans to invest $100 million in venture capital in the region over the next several years.
MorePurdue University launches Center for Energy Systems and Policy to meld research, business, public policy
November 10, 2008
Chris O'MalleyLast month, Purdue University launched the Center for Energy Systems and Policy to make sure its researchers
are working early in the process with business and public-policy experts at the university.
MoreSponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
First, the Athenaeum is going to have to get past the hurdle with the Lockerbie residents and the agreement that the parcel would be residential. Second, and in my opinion, this prime piece of property should include parking, PLUS, a black box theater(s), some market rate and affordable artist housing and a plan to renovate and reconfigure the second story theater. I would negotiate to add the DeHaan property surface parking lot into the development mix, place a one story surface parking garage on the DeHaan lot on the street level (for the Dehaan tenants use during the daytime) and add a second story to the garage that would become an addition to the current second story theater and then change the direction of the theater by moving the stage across the alley and on top of the DeHaan lot parking. You can add all the stage elements that are currently missing from the Athenaeum stage to make it more attractive for use by Ballet, Opera and traveling productions. Plus, the theater changes would probably help solve some of the soundproofing issues. Alas,it does not seem to be a part of the strategic plan to conduct a study to determine best use of the property. Seems like the current plan is a quick and easy move that ignores the property best use/potential and any strategic property planning for the effect on future generations.
I recall that MSA's pilings are still in the ground and hard to remove. It’s not likely any proposal will include significant underground construction/parking because of this. Start adding 2 floors of retail, 8 floors of parking and 5-10 floors of possible hotel, and/or 10-20 floors of residential, and you are at 30 floors already with possible expansion of all the uses. But then again I could be wrong.
Accoriding to their website there is no deadline to the Do Not Call list. What is this article referring to??
On what planet are they entitled to this largesse from the stockholders? These people make multi-million dollar salaries: Pay for your own personal travel.
It matters because they're already paid enormously fat salaries: Pay for your own personal travel. Being "taxed on it" isn't a valid excuse--so what? They're still being gifted a raft of luxury perks from somebody else's money on top of an enormous, lavish salary.